| BioID | bio3576 |
| Name | PAXALISIB |
| ChEMBL ID | CHEMBL3813842 |
| Molecular Formula | C18H22N8O2 |
| Molecular Weight | 382.43 |
| Molecular Weight (Monoisotopic) | 382.1866 |
| Type | Small molecule |
| Max Phase | Phase 2 |
| Target ID | Tar18 |
| Target Name | Serine/threonine-protein kinase cot (COT) |
| Synonyms | G-02441729|G02441729|GDC-0084|GDC0084|PAXALISIB|RG-7666 |
| Smiles | CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12 |
| Inchi | InChI=1S/C18H22N8O2/c1-18(2)16-22-12-14(25-3-6-27-7-4-25)23-13(11-9-20-17(19)21-10-11)24-15(12)26(16)5-8-28-18/h9-10H,3-8H2,1-2H3,(H2,19,20,21) |
| Inchi Key | LGWACEZVCMBSKW-UHFFFAOYSA-N |
| Molecular Species | NEUTRAL |
| Targets | 233.0 |
| Bioactivities | 268.0 |
| Np Likeness Score | -0.99 |
| Records Key | ['PAXALISIB', 'PAXALISIB', '16', '107; GDC-0084', 'Paxalisib'] |
| Records Name | ['PAXALISIB', 'PAXALISIB', '5-(6,6-dimethyl-4-morpholino-8,9-dihydro-6H-[1,4]oxazino[4,3-e]purin-2-yl)pyrimidin-2-amine', 'Paxalisib', 'Paxalisib'] |
| Withdrawn Flag | False |
| Orphan | 0 |